[go: up one dir, main page]

ES8207217A1 - Procedimiento para la preparacion de un inactivador de alfa-amilasa - Google Patents

Procedimiento para la preparacion de un inactivador de alfa-amilasa

Info

Publication number
ES8207217A1
ES8207217A1 ES505959A ES505959A ES8207217A1 ES 8207217 A1 ES8207217 A1 ES 8207217A1 ES 505959 A ES505959 A ES 505959A ES 505959 A ES505959 A ES 505959A ES 8207217 A1 ES8207217 A1 ES 8207217A1
Authority
ES
Spain
Prior art keywords
inactivator
alpha
amylase
regulation
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES505959A
Other languages
English (en)
Other versions
ES505959A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19803038130 external-priority patent/DE3038130A1/de
Priority claimed from DE19813107106 external-priority patent/DE3107106A1/de
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of ES8207217A1 publication Critical patent/ES8207217A1/es
Publication of ES505959A0 publication Critical patent/ES505959A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/36—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE UN INACTIVADOR DE ALFA-AMILASA. CONSISTE EN CULTIVAR STREPTOMYCES TENDAE ATCC31210 O HAG 1266; A PARTIR DEL CULTIVO SE SEPARA EL INACTIVADOR CON AYUDA DE RESINAS DE ADSORCION O POR CROMATOGRAFIA DE FASE INVERTIDA Y A CONTINUACION SE PURIFICA, OBTENIENDOSE UN INACTIVADOR DE X''-AMILASA CONSISTENTE EN HOE 467-A CON UN PUNTO ISOELECTRICO 4,35,0,15 O BIEN HOE 467-B CON UN PUNTO ISOELECTRICO 4,53,0,15 O BIEN LOS DOS COMPONENTES. EL INACTIVADOR SEPARADO SE PURIFICA CON AYUDA DE INTERCAMBIADORES DE IONES A UN PH COMPRENDIDO ENTRE 4,4 Y 6. EL INACTIVADOR SEPARADO SE PURIFICA CON AYUDA DE INTERCAMBIADORES DE IONES A UN PH COMPRENDIDO ENTRE 4,4 PY 6.
ES505959A 1980-10-09 1981-10-02 Procedimiento para la preparacion de un inactivador de alfa-amilasa Granted ES505959A0 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19803038130 DE3038130A1 (de) 1980-10-09 1980-10-09 (alpha) -amylaseinaktivatoren sowie verfahren zu ihrer herstellung
DE19813107106 DE3107106A1 (de) 1981-02-26 1981-02-26 (alpha) -amylaseinaktivator und verfahren zu seiner herstellung

Publications (2)

Publication Number Publication Date
ES8207217A1 true ES8207217A1 (es) 1982-09-01
ES505959A0 ES505959A0 (es) 1982-09-01

Family

ID=25788382

Family Applications (1)

Application Number Title Priority Date Filing Date
ES505959A Granted ES505959A0 (es) 1980-10-09 1981-10-02 Procedimiento para la preparacion de un inactivador de alfa-amilasa

Country Status (9)

Country Link
US (1) US4451455A (es)
EP (1) EP0049847B1 (es)
AU (1) AU542795B2 (es)
CA (1) CA1172978A (es)
DE (1) DE3169418D1 (es)
DK (1) DK446481A (es)
ES (1) ES505959A0 (es)
FI (1) FI813108L (es)
NO (1) NO813407L (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5885899A (ja) * 1981-11-16 1983-05-23 Fujirebio Inc アミラ−ゼインヒビタ−およびその製造法
DE3331860A1 (de) * 1983-09-03 1985-03-21 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von tendamistat
DK520784A (da) * 1984-01-21 1985-07-22 Hoechst Ag Cycliske polypeptider, deres fremstilling og anvendelse
DE3738541A1 (de) * 1987-11-13 1989-05-24 Hoechst Ag Verfahren zur isolierung und reinigung von hirudin
DE3536182A1 (de) * 1985-10-10 1987-04-16 Hoechst Ag Promotor-anordnung fuer streptomyceten-vektoren
WO1996012730A1 (en) * 1994-10-20 1996-05-02 Industrial Research Limited Separation of amino acids and peptides from protein hydrolysates
JP2007512359A (ja) 2003-11-19 2007-05-17 メタバシス・セラピューティクス・インコーポレイテッド 新規なリン含有甲状腺ホルモン様物質
US7262318B2 (en) * 2004-03-10 2007-08-28 Pfizer, Inc. Substituted heteroaryl- and phenylsulfamoyl compounds
US20050288340A1 (en) * 2004-06-29 2005-12-29 Pfizer Inc Substituted heteroaryl- and phenylsulfamoyl compounds
KR20070084455A (ko) * 2004-11-23 2007-08-24 워너-램버트 캄파니 엘엘씨 지질혈증 치료용 ｈｍｇ ｃｏ-ａ 환원효소 억제제로서의7-(2ｈ-피라졸-3-일)-3,5-디히드록시-헵탄산 유도체
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
EP2094643B1 (en) 2006-12-01 2012-02-29 Bristol-Myers Squibb Company N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
WO2008151257A2 (en) 2007-06-04 2008-12-11 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
US20100120694A1 (en) 2008-06-04 2010-05-13 Synergy Pharmaceuticals, Inc. Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
ES2624828T3 (es) 2008-07-16 2017-07-17 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
US20120046364A1 (en) 2009-02-10 2012-02-23 Metabasis Therapeutics, Inc. Novel Sulfonic Acid-Containing Thyromimetics, and Methods for Their Use
WO2011145022A1 (en) 2010-05-21 2011-11-24 Pfizer Inc. 2-phenyl benzoylamides
WO2012027331A1 (en) 2010-08-27 2012-03-01 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
JP2014513923A (ja) 2011-03-04 2014-06-19 ファイザー・インク Ｅｄｎ３様ペプチドおよびその使用
US20150050371A1 (en) 2012-03-09 2015-02-19 Biotropics Malaysia Berhad Extract Formulations of Rhodamnia Cinerea And Uses Thereof
JP2016514671A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼのアゴニストおよびその使用
JP2016514670A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド 他の薬物と組み合わせたグアニル酸シクラーゼ受容体アゴニスト
SG11201507496UA (en) 2013-04-17 2015-11-27 Pfizer N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
HRP20240805T1 (hr) 2013-06-05 2024-09-27 Bausch Health Ireland Limited Ultra-pročišćeni agonisti guanilat-ciklaze c, postupak njihove pripreme i uporabe
EP3186242B1 (en) 2014-08-29 2021-10-06 Tes Pharma S.r.l. Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
CA3038185A1 (en) 2016-10-14 2018-04-19 Tes Pharma S.R.L. Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase
MX2021005904A (es) 2018-11-20 2021-09-08 Tes Pharma S R L Inhibidores de la ácido alfa-amino-beta-carboximucónico semialdehído descarboxilasa.
CN119112897A (zh) 2019-01-18 2024-12-13 阿斯利康(瑞典)有限公司 Pcsk9抑制剂及其使用方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5125232B1 (es) * 1965-02-24 1976-07-29
DE2701890C2 (de) * 1977-01-19 1983-08-04 Hoechst Ag, 6230 Frankfurt Peptielischer Glycosidhydrolase-Inhibitor aus einem Streptomyceten und seine Verwendung

Also Published As

Publication number Publication date
EP0049847A2 (de) 1982-04-21
NO813407L (no) 1982-04-13
FI813108L (fi) 1982-04-10
US4451455A (en) 1984-05-29
EP0049847B1 (de) 1985-03-20
AU542795B2 (en) 1985-03-14
DE3169418D1 (en) 1985-04-25
DK446481A (da) 1982-04-10
EP0049847A3 (en) 1982-08-25
ES505959A0 (es) 1982-09-01
CA1172978A (en) 1984-08-21
AU7615081A (en) 1982-04-22

Similar Documents

Publication Publication Date Title
ES8207217A1 (es) Procedimiento para la preparacion de un inactivador de alfa-amilasa
DE3260794D1 (en) Cyclic carbonic acid derivatives, process for their preparation and their use as copolymerisation constituents for the preparation of polycarbonates
IL75637A (en) Thymopentin analogs and pharmaceutical compositions containing them
IL67572A (en) Trans-2-aza bicyclo(3.(3+n).o)alkane-3-carboxylic acid derivatives,processes for their preparation and pharmaceutical compositions containing them
GEP20084347B (en) New derivatives of diphosphonic acid, method for their preparation and medicamentous form containing them
EP0263569A3 (en) 9-alpha-hydroxysteroids,process for their preparation,process for the preparation of the corresponding 9(11)-dehydro-derivatives and pharmaceutical preparations containing said steroids
MY103850A (en) Phenol substituted gem-diphosphonate derivatives, process for their preparation and pharmaceutical compositions containing them.
WO1993016719A3 (en) Use of platelet derived growth factor in ophthalmic wound healing
AU3062384A (en) Cyclic pentapeptides displaying somatostatin antagonism and method of treatment of mammals therewith
SG102892G (en) Composition of pregnanolole comprising a stable oil-in-water emulsion
AU2674288A (en) Process for the preparation of diorganopolysiloxanes containing triorganosiloxy groups as terminal units
AU1082988A (en) 5-hydroxy-3-aminochroman compounds, processes for their preparation, pharmaceutical compositions containing them and methods of treatment therewith
DK583785A (da) Soedemiddel, fremgangsmaade til fremstilling deraf og anvendelse deraf
EP0331755A4 (en) Medicine-containing fat emulsion of the type prepared immediately before use and process for preparing medicine-containing fat emulsion
EG18005A (en) Composition of the activation of fermentative processes and process for the acceleration of the fermentative degradation of natural products
ES8600752A1 (es) Un procedimiento para la preparacion de nuevos derivados de tiosulfonamida.
HUT45972A (en) Process for production of derivatives of subsituated amin-methil-5,6,7,8-tetrahydronaphtil-oxi-acetic acid, of medical compositions containing such substances and also of the intermediers
ES8304152A1 (es) Procedimiento para la obtencion de derivzados de aminociclitol.
GB2109796B (en) Anorexigenic tripeptides, process for the preparation thereof and pharmaceutical compositions containing them
EP0235904A3 (en) Treatment of allergy with thymopentin
DE3160797D1 (en) 11-alpha-amino androstanes, pharmaceutical compositions containing them and processes for their preparation
IL81213A (en) Fluorinated diaminoalkyne derivatives,process for their preparation and pharmaceutical compositions containing them
AU8019294A (en) Methodologies for extracting and using muira puama
US3098792A (en) Process for preparing product having enhanced lactogenic activity
AU2659288A (en) Dipeptide compounds, processes for their preparation and compositions containing them

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19980504